Drawing for YOUR FOUNTAIN OF YOUTH

USPTO serial 79324818

YOUR FOUNTAIN OF YOUTH

Reviewed by CopyMark Law Group

Reg. 7082461Status 700Registered
Filing date
Status date
Registration date
Jun 20, 2023
Examiner
LOZEAU, BRANDON THOMAS
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with YOUR FOUNTAIN OF YOUTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Julianne Abelman

Julianne Abelman Womble Bond Dickinson (US) LLP950 3rd Avenue, Suite 2400New York, NY 10022United States

Goods and services

ClassDescriptionStatusFirst use
001Stem cell preparations used for research of peripheral neuropathy, peripheral vascular disease, critical limb ischemia, wound care, end-stage heart diseases, angina pectoris, ischemic and dilated cardiomyopathy, COPD, idiopathic pulmonary hypertension and other diseases of ischemia; biomedical autologous preparations in the nature of hematopoietic stem cells that include a synergetic cell population of angiogenic cell precursors used for research, other experiments of minor health disorders to prevent them from becoming severe health disordersACTIVE—
005Stem cell preparations used for the treatment of peripheral neuropathy, peripheral vascular disease, critical limb ischemia, wound care, end-stage heart diseases, angina pectoris, ischemic and dilated cardiomyopathy, COPD, idiopathic pulmonary hypertension and other diseases of ischemia; biomedical autologous preparations in the nature of hematopoietic stem cells that include a synergetic cell population of angiogenic cell precursors used for the treatment of minor health disorders to prevent them from becoming severe health disorders, and to treat severe health disorders on an ongoing basis to slow, eliminate, or reverse their progressACTIVE—
042Research and development in the field of blood, blood products being comprised of a synergistic cell population of stem cells including angiogenic cell precursors, and blood testing; scientific research services in the field of blood and stem cellsACTIVE—
044Services in the medical field, namely, medical services performed in a laboratory for medical research companies, the foregoing consisting of extracting, processing, culturing, testing, injecting or administering under medical supervision the products derived from blood and blood components being a novel human cell population; services in the medical field, namely, medical services performed in a laboratory for medical research companies, the foregoing consisting of selecting, processing, manipulating, purging and storing stem cells from blood and adding regenerative cells to the bodyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 24, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 26, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Apr 26, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 26, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 26, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 10, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 21, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 21, 2023FIMPFINAL DISPOSITION PROCESSED—
Sep 20, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 20, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 20, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 5, 2023GPNXNOTIFICATION PROCESSED BY IB—
Apr 4, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 4, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 15, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 15, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 15, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 27, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 27, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Feb 27, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 27, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 27, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 7, 2023RFNTREFUSAL PROCESSED BY IB—
Jan 31, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jan 31, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 31, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 10, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 9, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 9, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 27, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 27, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 27, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 13, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 13, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 13, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 20, 2022DOCKASSIGNED TO EXAMINER—
Jul 5, 2022RFNTREFUSAL PROCESSED BY IB—
Jun 15, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 15, 2022RFRRREFUSAL PROCESSED BY MPU—
May 17, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 16, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 10, 2022CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
May 2, 2022CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Feb 7, 2022DOCKASSIGNED TO EXAMINER—
Nov 12, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 8, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 4, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance